Pretreatment daily image-guided radiation therapy (IGRT), which can be efficiently performed, was beneficial to all patients at a radiology facility in Australia, according to a study published online Nov. 23 in the Journal of Medical Imaging and Radiation Sciences.

Calculating comorbidity-adjusted life expectancy could help physicians determine whether to continue or cease cancer screening in elderly patients, according to a study published Nov. 18 in Annals of Internal Medicine.

To diagnose and treat the most serious diseases, such as cancer, patients sometimes have to endure some tough love. Radiotherapy and chemotherapy can take a serious toll on a person, even if the reward of being rid of their cancer is worth the risk.

The American Society of Clinical Oncology (ASCO) has released its top five list of tests, procedures, and treatments whose common use and clinical value are not supported by available evidence as part of the American Board of Internal Medicine’s Choosing Wisely Campaign.

Cleveland Clinic Innovations has formed a spin-off company, Cleveland Diagnostics Inc., to develop and commercialize cancer diagnostics and screening tests.

After years of steady increase, colorectal cancer screening rates may be leveling off, according to the Centers for Disease Control and Prevention’s (CDC’s) latest “Vital Signs” report released online Nov. 5. The report found that 23 million people between the ages of 50 and 75 years old are not getting the testing recommended by the United States Preventive Services Task Force (USPSTF).

Pairing the diabetes drug, metformin, with chemoradiation therapy treatment for aggressive lung cancer may slow tumor growth and recurrence, according to researchers at the Perelman School of Medicine at the University of Pennsylvania.

Print and web-based decision aids (DAs) could be beneficial informants in prostate cancer screening decision-making processes, according to a study published on Oct. 14 in JAMA Internal Medicine.